Discovery Biology/Immunology Co-op (July-Dec)

Bristol-Myers Squibb
0 reviews

Posted on: 12 Feb 2021

Cambridge, MA

Apply on Company site Save this job

Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

We are seeking an enthusiastic and talented student scientist interested in immunology, autoimmunity and immune suppression. We offer a highly energetic, vibrant, and dynamic environment to help prepare you for a career in scientific research. You will be responsible for running cell-based assays under guidance to support drug development, as well as designing and executing exploratory studies to understand mechanism of action of drug candidates. You will work closely with and learn from a diverse group of scientists pursuing key questions and targets in immune suppression space. You will have opportunities to develop biology research skills, present your work to colleagues, participate in scientific discussions and project meetings, and be exposed to all aspects of cross-functional early-stage drug discovery process.

Key Responsibilities

* Under guidance, design and execute cell-based immunological assays to advance drug candidate profiling and mechanistic understanding of targets
* Analyze, interpret, and present data, perform QC and troubleshooting
* Maintain detailed written record of experiments and results and promptly communicate key information to stakeholders
* Continuously educate yourself on key immunological pathways and processes relevant to the project, as well as laboratory techniques

Qualifications & Experience

* An academic background in molecular and cell biology and/or immunology and a strong academic record ( 3.2 GPA); working knowledge of key immunology concepts
* Training in cell culture and key cell biology techniques; at least three semesters of laboratory course work and/or research
* Prior laboratory experience in industry or academic setting is desired
* Prior experience in cell-based assay development, familiarity with high-throughput and multiplex assays is a plus
* Excellent communication skills and team spirit required
* Enthusiasm for science and strong drive to learn

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Bristol-Myers Squibb

New York, New York

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.

It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.

The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.